Literature DB >> 23043319

Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph+ lymphoid blast crisis of chronic myeloid leukaemia.

Massimo Breccia, Alessandra Serrao, Adriano Salaroli, Giuseppina Loglisci, Irene Zacheo, Giuliana Alimena.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23043319     DOI： 10.1111/bjh.12079

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

1.  Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.

Authors:  Hong-Quan Duong; Yong Weon Yi; Hyo Jin Kang; Insoo Bae; Young-Joo Jang; Sahng-June Kwak; Yeon-Sun Seong
Journal:  Int J Oncol       Date:  2014-03-21       Impact factor: 5.650

Review 2.  Understanding and Monitoring Chronic Myeloid Leukemia Blast Crisis: How to Better Manage Patients.

Authors:  Lulu Wang; Li Li; Rongrong Chen; Xianbo Huang; Xiujin Ye
Journal:  Cancer Manag Res       Date:  2021-06-23       Impact factor: 3.989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.